These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26899776)

  • 21. Improving the Combination Pneumococcal Vaccination Rate in Systemic Lupus Erythematosus Patients at an Adult Rheumatology Practice.
    Garg S; Tsagaris K; Cozmuta R; Lipson A
    J Rheumatol; 2018 Dec; 45(12):1656-1662. PubMed ID: 30173154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza vaccination in systemic lupus erythematosus: safe and protective?
    Holvast B; Huckriede A; Kallenberg CG; Bijl M
    Autoimmun Rev; 2007 Apr; 6(5):300-5. PubMed ID: 17412302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New perspectives in the classification and treatment of systemic lupus erythematosus: the central role of kidney involvement].
    Cavagna L; Scorletti E; Romano M; Cagnotto G; Caporali R
    G Ital Nefrol; 2013; 30(4):. PubMed ID: 24403199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infections in the lupus patient: perspectives on prevention.
    Barber C; Gold WL; Fortin PR
    Curr Opin Rheumatol; 2011 Jul; 23(4):358-65. PubMed ID: 21532484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal Vaccination Among Lupus Patients: Who Are the Recipients?
    Arora S; Nika A; Sequeira W; Block JA; Jolly M
    J Clin Rheumatol; 2021 Dec; 27(8):e456-e461. PubMed ID: 32804752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.
    van Vollenhoven RF; Mosca M; Bertsias G; Isenberg D; Kuhn A; Lerstrøm K; Aringer M; Bootsma H; Boumpas D; Bruce IN; Cervera R; Clarke A; Costedoat-Chalumeau N; Czirják L; Derksen R; Dörner T; Gordon C; Graninger W; Houssiau F; Inanc M; Jacobsen S; Jayne D; Jedryka-Goral A; Levitsky A; Levy R; Mariette X; Morand E; Navarra S; Neumann I; Rahman A; Rovensky J; Smolen J; Vasconcelos C; Voskuyl A; Voss A; Zakharova H; Zoma A; Schneider M
    Ann Rheum Dis; 2014 Jun; 73(6):958-67. PubMed ID: 24739325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections.
    Luijten RK; Cuppen BV; Bijlsma JW; Derksen RH
    Lupus; 2014 Dec; 23(14):1512-6. PubMed ID: 25078055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical practice guidelines for the treatment of systemic lupus erythematosus by the Mexican College of Rheumatology.
    Xibillé-Friedmann D; Pérez-Rodríguez M; Carrillo-Vázquez S; Álvarez-Hernández E; Aceves FJ; Ocampo-Torres MC; García-García C; García-Figueroa JL; Merayo-Chalico J; Barrera-Vargas A; Portela-Hernández M; Sicsik S; Andrade-Ortega L; Rosales-Don Pablo VM; Martínez A; Prieto-Seyffert P; Pérez-Cristóbal M; Saavedra MÁ; Castro-Colín Z; Ramos A; Huerta-Sil G; Hernández-Cabrera MF; Jara LJ; Limón-Camacho L; Tinajero-Nieto L; Barile-Fabris LA
    Reumatol Clin (Engl Ed); 2019; 15(1):3-20. PubMed ID: 29735288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases.
    Heijstek MW; Ott de Bruin LM; Bijl M; Borrow R; van der Klis F; Koné-Paut I; Fasth A; Minden K; Ravelli A; Abinun M; Pileggi GS; Borte M; Wulffraat NM;
    Ann Rheum Dis; 2011 Oct; 70(10):1704-12. PubMed ID: 21813547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Systemic lupus erythematosus--myths and dogma].
    Schifferli JA
    Ther Umsch; 2005 May; 62(5):292-6. PubMed ID: 15945219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management].
    Trujillo-Martín MM; Rúa-Figueroa Fernández de Larrinoa I; Ruíz-Irastorza G; Pego-Reigosa JM; Sabio Sánchez JM; Serrano-Aguilar P;
    Med Clin (Barc); 2016 May; 146(9):413.e1-14. PubMed ID: 26975887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal.
    Tselios K; Koumaras C; Urowitz MB; Gladman DD
    Semin Arthritis Rheum; 2014 Feb; 43(4):521-5. PubMed ID: 23953498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of systemic lupus erythematosus associated with vaccines: an international case-control study.
    Grimaldi-Bensouda L; Le Guern V; Kone-Paut I; Aubrun E; Fain O; Ruel M; Machet L; Viallard JF; Magy-Bertrand N; Daugas E; Rossignol M; Abenhaim L; Costedoat-Chalumeau N;
    Arthritis Rheumatol; 2014 Jun; 66(6):1559-67. PubMed ID: 24591123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Systemic lupus erythematosus: a French general hospital experience].
    Lecapitaine AL; Bakir R; Delassus JL; Gros H; Bouldouyre MA
    Sante Publique; 2017 Mar; 29(1):47-55. PubMed ID: 28737325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of vaccination of patients with systemic lupus erythematosus.
    Abu-Shakra M
    Lupus; 2009 Nov; 18(13):1205-8. PubMed ID: 19880569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future--the EULAR recommendations for the management of SLE and the use of end-points in clinical trials.
    Bertsias G; Gordon C; Boumpas DT
    Lupus; 2008 May; 17(5):437-42. PubMed ID: 18490423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [How to minimize the risk of infection in systemic lupus erythematosus?].
    Costedoat-Chalumeau N; Groh M; Piette JC; Launay O
    Rev Med Interne; 2019 Jun; 40(6):347-350. PubMed ID: 29937299
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
    Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.
    Yildirim Cetin G; Sayar H; Ozkan F; Kurtulus S; Kesici F; Sayarlioglu M
    Lupus; 2013 Jul; 22(8):839-46. PubMed ID: 23761100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.